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Intestinal trefoil factor increased the Bcl-2 level in a necrotizing
enterocolitis neonate rat model
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Background/aim: The aim of this study was to investigate the therapeutic effect of intestinal trefoil factor (ITF) on necrotizing
enterocolitis (NEC) by observing the pathological changes and detecting the protein level differences in Caspase-3, Bax, and Bcl-2 in
an NEC neonate rat model.
Materials and methods: A Wistar rat model of NEC was established and 30 one-day-old neonate Wistar rats were randomly divided
into three groups including a normal control (group A), NEC rats treated with 0.2 ml physiological saline through intraperitoneal (i.p.)
injection (group B), and NEC rats treated with 0.2 mg ITF by i.p injection (group C).
Results: Compared with group B, there were statistically significant differences in Caspase-3, Bax, and Bcl-2 levels in groups A and C
(P < 0.05). Moreover, there was a significant difference in the Bcl-2 level between groups A and B (P < 0.05).
Conclusion: ITF alleviated injury of the intestinal tract in neonate rats with NEC and this mechanism was possibly related to a reduction
in the expression of Caspase-3 and Bax and the increase in Bcl-2 expression.
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1. Introduction
Necrotizing enterocolitis (NEC) is one of the most severe
diseases threatening newborn lives (1), with an incidence
rate ranging from 0.72% to 2.10%. Moreover, there is a
high incidence rate of NEC in low birth weight infants
(2). Furthermore, only 7%–15% of all NEC cases occur in
term or late preterm infants. The age of onset of NEC is
inversely related to the postmenstrual age of the mother
at the time of birth (3). Additionally, the mortality rate
of NEC is 16%–20%, and there is a higher mortality
rate in infants with serious NEC, very low birth weight
infants, and NEC infants who need surgical therapy (4,5).
Presently, NEC is caused by bowel necrosis due to many
factors such as premature birth, infection, hypoxia, enteral
feeding, and intestine ischemia. The main therapy for NEC
is surgery to remove the necrotic bowels. However, the
surgery can cause short bowel syndrome and inadequate
absorption of nutrients. Thus, better therapeutic measures
are needed (6,7). Studies have indicated that the scores
for neonatal acute physiology-perinatal extension-II and
metabolic derangement acuity were insufficient measures
* Correspondence: binghongzhangcn@126.com

for deciding on surgical treatment for the patients affected
by NEC (8). A study from Hong Kong found that the
intestinal trefoil factor (ITF) 3 level was higher in NEC
patients than in non-NEC patients, suggesting that NEC
affects ITF production (9). ITF is a member of the trefoil
family and may protect the mucosa from insult, stabilize
the mucus layer, and affect healing of the epithelium
(10). The current study explores the effect of ITF on the
expression of Caspase-3, Bax, and Bcl-2 in order to better
understand the relationship between these three proteins
and NEC.
2. Materials and methods
2.1. NEC model
Thirty one-day-old Wistar rat pups (5–10 g) were provided
by the Hubei Provincial Center for Disease Control and
Prevention, Wuhan, China. An AE2200 electronic balance
was obtained from Mettler Toledo Company, Shanghai,
China. Infant formula (Dumex, Dumex Infant Food Co.,
Ltd. Shanghai, China) was fed to the neonate rats (200
kcal/kg per day) every 3 h, with an initial volume of 0.1
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mL per feeding that was increased as the weight of the
rats increased (4). The room temperature was maintained
at 15%–25 °C and rats were exposed to natural light.
Hypoxia was induced by exposing each rat pup to 100%
nitrogen (maintaining 99.96 ± 0.2% for 60 s measured by
an RSS-5100 portable digital oxygen recorder (Shanghai
REX Instrument factory, Shanghai, China)), followed by
exposure to cold (4 °C) for 10 min two times daily. The
newborn rats were returned to the female rats to feed
following treatment for 3 days. All newborn rats were
killed by decollation on day 4. The intestinal tract tissues
from the duodenal inferior to the upper rectum were
isolated. Indicators of NEC were noted including colored
intestine, bleeding, tympanites, or narrowing of the ileum.
Segments of 1–2 cm from the near distal duodenum, small
bowel, and Terminal caecum were fixed with 10% formol
saline and embedded with paraffin. Then, the expression
of caspase-3 was detected by tectological examination
and spectrophotometry. Bax and Bcl-2 protein levels were
measured using the immunohistochemical technique.
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
The animal use protocol was reviewed and approved by the
Institutional Animal Care and Use Committee (IACUC)
of Wuhan University.
2.2. Animals and groups
Thirty rat pups were randomly divided into three groups
and each group had 10 rats. In group A, the rats were left
untreated as a control. Group B rats were injected with 0.2
mL of physiological saline solution intraperitoneally, and
group C NEC rats were injected with 0.2 mL of ITF.
2.3. Spectrophotometry
Dissected intestinal tract tissues were washed in cold
normal saline solution and then weighed after drying
with filter paper. Then, 5 mg of tissue was added to 100
µL of lysate and the tissues were homogenized on ice,
transferred into 1.5 mL Eppendorf tubes, and kept on ice
for an additional 5 min. Next, tubes were centrifuged at
16,000 rpm for 15 min at 4 °C. Then, the supernatant was
collected, transferred into cold tubes, and stored at –20
°C. The protein quantification and detection of caspase-3
activity were performed using caspase-3 activity test kits
(Beyotime Institute of Biotechnology, Jiangsu, China)
according to the manufacturers’ instructions. The peptide
nucleic acid (pNA) level was calculated using standard
curves to obtain the caspase-3 activity.
2.4. Immunohistochemistry
The SP immunohistochemical technique was used to detect
the Bax and Bcl-2 protein levels in the intestinal tissues.
SP staining kits were purchased from Beijing ZSGB-Bio
Company, Beijing, China. All samples were fixed with 10%
formalin and embedded with paraffin, cut to a thickness
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of 4 µm, and mounted on glass slides. Paraffin-embedded
intestinal sections were deparaffinized, immersed in
sodium citrate buffer, and heated at 96–100 °C for 15 min
prior to treatment with 3% hydrogen peroxide for 10 min
to block endogenous peroxidase activity. Antigen retrieval
was performed using a microwave. The specimens were
washed twice with distilled water and then with PBS for
3 min each and incubated with 10% normal serum for 10
min at room temperature. Then, samples were incubated
overnight with rat antihuman monoclonal Bcl-2 antibody
(Beijing ZSGB-Bio Company, Beijing, China) and rat
antihuman monoclonal Bax antibody (Beijing ZSGBBio Company, Beijing, China) at a dilution of 1:200. The
sections were washed three times with PBS for 3 min each
and incubated with biotin-labeled anti-rat IgG for 10 min
at room temperature. After three washes with PBS for 3 min
each, SP was added at 37 °C for 10 min, and the staining was
visualized with 3,3’-diaminobenzidine tetrahydrochloride
chromogen (Beijing ZSGB-Bio Company, Beijing, China).
A nuclei counterstain was performed using hematoxylin.
2.5. Pathological examination
Experimental rat pups were killed on day 4 and 1–2 cmlong specimens were taken from the ileocecal segments
of the intestinal tissues for histological study. After 10%
formalin fixation and paraffin embedding, the processed
and sectioned (4–6 µm) tissues were stained with
hematoxylin and eosin. Five sections were obtained from
each rat and 5 fields of each section were microscopically
observed (×200). The criteria for each histological grade
(0–4 score) were as follows: normal (0), no damage
and intact chorioepithelilum; mild (1), slight edema of
chorioepithelilum; moderate (2), slight middle-end villus
necrosis; severe (3), severe middle-end villus necrosis and/
or severe edema in the submucosal and muscular layers
and regional villus sloughing; necrosis (4).
2.6. Statistical analysis
Statistical analyses were performed using the statistical
software package SPSS13.0. The pathological scores were
measured by Ridit analysis. Bax and Bcl-2 protein levels
were analyzed using the optical intensity values. The image
analysis software was from HPIAS2000 (Qianpin Image
Engineering Company, Tongji, China). Data are expressed as
the means ± standard deviation. The data were analyzed for
significant differences with one-way ANOVA. A q-test was
used to compare groups. P < 0.05 was considered significant.
3. Results
3.1. Expression of Caspase-3, Bax, and Bcl-2
In normal rat pups, there was less expression of caspase-3
in the intestinal tissues when compared with NEC rats.
The Caspase-3 contents in group B were the highest, while
the Caspase-3 contents in groups A and C were lower.
There were significant differences in caspase-3 expression
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between groups A and B (q = 15.88, P < 0.05) and between
groups B and C (q = 14.98, P < 0.05). However, there was
no significant difference between groups A and C (q = 0.9,
P > 0.05).
The expression of Bcl-2 protein was negative in
the normal mucous membrane. Positive brown-yellow
particles indicated that Bax and Bcl-2 were located in the
plasma. Bax and Bcl-2 protein levels were analyzed using
the optical intensity values. The Bax protein expression
was highest in group B, and there was a significant
difference between groups A and B (q = 2.95, P < 0.05)
and between groups B and C (q = 2.79, P < 0.05), but there
was no significant difference between groups A and C
(q = 0.17, P > 0.05). Moreover, the protein expression of
Bcl-2 was highest in group C, and there was a significant
difference between groups A and B (q = 3.51, P < 0.05) and
between groups B and C (q = 5.30, P < 0.05). There was
also a significant difference between groups A and C (q =
8.81, P < 0.05, Table).
3.2. Comparison of pathological changes
The pathological scores ranged from 0 to 2 in the tissue
from group C, which exhibited small congested blood
vessels and few necrotic cells of the villi. The pathological
scores ranged from 1 to 4 in the tissue from group B, which
exhibited superficial epithelium lesions and full mucous
membrane necrosis. Moreover, intestinal tract lesion were
slighter in groups C and A than in group B, and there was
no significant difference between groups A and C.
4. Discussion
NEC is caused by several factors such as prematurity,
enteral feeding, and infection (11). The trefoil factor family
consists of small polypeptides secreted by mucins in the
gastrointestinal tract. Suemori et al. (12) found ITF in rat
jejunums in 1991. Under physiological conditions, ITF is
mainly expressed in the goblet cells of the intestines and
colon, and is also found in the ducts of the pancreas, uterus,
hypothalamus, and pituitary gland (13). The cloverleaf
pattern structure made by the TFF3s exhibits antiprotease
hydrolysis, acid digestion, and heat resistance. The present
study indicated that ITF was cryoprotective and reduced

the impairment of the intestinal mucosa mediated by
many kinds of injury factors. Interestingly, ITF not only
promoted cell proliferation and migration, but also special
physical function; for example, it helped to stabilize the
mucus layer by binding to mucous glycoprotein (14,15).
Additionally, experiments have shown that ITF plays an
important role in protecting the integrity of the intestinal
mucosa and promoting its reconstruction after injury
(16–19). Mice lacking ITF did not heal well after mucosa
injury. In this study, the histopathological results showed
that ITF alleviated the intestinal lesions in NEC rats.
Caspases or cysteine-aspartic proteases are essential
for helping to regulate apoptosis in cells. Thus, caspases
are also called executioner proteases. Caspase 3 is the
key protease that mediates cell apoptosis (20). Moreover,
caspase 3 is the most critical protease in the caspase
cascade reaction. As an executioner caspase, the caspase-3
zymogen has virtually no activity until it is cleaved by
an initiator caspase after apoptotic signaling events have
occurred. Our results showed that the expression of
caspase-3 was significantly increased in the NEC rat group
compared with the control group, but was decreased in the
NEC group after treatment with ITF.
Bcl-2 is derived from B-cell lymphoma 2 and is classified
as an oncogene. When the expression of Bcl-2 protein
is increased, apoptosis is inhibited, increasing the cell
survival time (21). Bax was the first proapoptotic member
of the Bcl-2 protein family to be identified. Bax can form
Bax-Bax homodimers that act as proapoptotic regulators,
but Bcl-2 may affect the formation of these homodimers.
An abnormal increase in Bcl-2 results in the increased
separation of Bax-Bax homodimers and the formation
of more stable Bax-Bcl-2 heterodimers, with Bcl-2
suppressing cell apoptosis. Therefore, the ratio of Bcl-2 and
Bax is an important factor determining the sensitivity of the
apoptosis signal stimulated by cells. The overexpression of
Bcl-2 protein could inhibit cell apoptosis, but an increase
in Bax homodimers promotes cell apoptosis. Chan et al.
(22) found that antisense ITF significantly enhanced cell
apoptosis induced by adriamycin, and Taupin et al. (23)
also suggested that endogenous ITF protected the colonic

Table. Expressions of Caspase-3 (µmol), Bax and Bcl-2 in rat intestinal tissues.
Group

N

Caspase-3 (µmol)

Bax

Bcl-2

A

10

6.72 ± 1.45

2.19 ± 0.61

1.64 ± 0.38

B

10

22.60 ± 2.93

5.15 ± 0.14

5.14 ± 0.54

C

10

7.62 ± 2.16

2.36 ± 0.40

10.45 ± 1.79

F value

40.23

152.3

162.78

P value

<0.05

<0.05

<0.05
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cell line from apoptosis induced by serum starvation and
ceramide-C2. This effect was dependent on the activity
of PI3-kinase. This study demonstrated that ITF may
prevent p53-dependent and p53-independent apoptosis.
In addition, some studies implied that ITF inhibited cell
apoptosis through activation of the Akt/PKB/NF-κB (p65)
pathway (17,24). Our results indicated that Bax and Bcl-2
were expressed more in the NEC group than in the control
group, and the expression of Bax was decreased in the ITF
treatment group. Conversely, the expression of Bcl-2 was
increased in the ITF treatment group compared with the
NEC group. Both Bax and Bcl-2 proteins are downstream
regulators of cell apoptosis following the activation of the
Akt or P53 pathway. Thus, our results are consistent with
previous findings.
It has been indicated that cytC is released from the
mitochondrial inner membrane in the early stages of
apoptosis in order to launch the mitochondrial apoptosis

pathway (25). The release of cytC results in the release of
the mitochondrial transition pores and the induction of
the proapoptosis gene Bax. However, the antiapoptotic
gene Bcl-2 can block the release of cytC and the activation
of caspase (26). This study showed that the expression
of Caspase-3 and Bax were increased in the NEC groups
with and without ITF treatment, and their expression
decreased in intestinal tissues, while the expression of Bcl2 significantly increased. The protective effect of ITF on
intestinal cells should be further studied.
In summary, this study demonstrated that the
expressions of Caspase-3 and Bax were decreased in
intestinal tissues after treatment of NEC rats with ITF,
but the expression of the Bcl-2 gene was increased. The
findings indicate that these three genes are involved in the
occurrence and development of NEC. The results from this
study provide critical information needed for the future
development of a target-gene therapy for NEC.
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